Skip to main content

Day: June 12, 2025

Montage Gold Closes Second Tranche of Investment in African Gold

VANCOUVER, British Columbia, June 12, 2025 (GLOBE NEWSWIRE) — Montage Gold Corp. (“Montage” or the “Company”) (TSX: MAU, OTCQX: MAUTF) is pleased to announce the closing of the second tranche of its previously announced strategic investment in African Gold Limited (“African Gold”) (ASX:A1G). The strategic partnership consists of a share exchange transaction between Montage and African Gold (the “Share Exchange Transaction”) including the issuance to Montage of 92,377,787 fully paid ordinary shares of African Gold (“African Gold Ordinary Shares”) at deemed issue price of A$0.07 per African Gold Ordinary Share, and the issuance to African Gold of 2,026,388 common shares of Montage (“Montage Common Shares”) at a deemed issue price of C$2.87 per Montage Common Share. Montage and African Gold have closed Tranche 2 of the Share Exchange...

Continue reading

Liberty Gold Reports Voting Results from Annual General Meeting and Changes to the Board of Directors and Management

VANCOUVER, British Columbia, June 12, 2025 (GLOBE NEWSWIRE) — Liberty Gold Corp. (TSX: LGD; OTCQX: LGDTF) (“Liberty Gold” or the “Company”) is pleased to announce voting results from the Company’s Annual General Meeting of Shareholders held on June 12, 2025 (the “Meeting”). Cal Everett, who has been the CEO and director of the Company, retired effective today as the CEO and did not stand for re-election as director at the Meeting. Greg Etter, newly appointed Chair of Liberty Gold, stated, “We’d like to thank Cal for his commitment to Liberty Gold as well as his inimitable leadership, we look forward to continuing the relationship as he takes on the role of Strategic Financial Advisor. We’d also like to thank Rob Pease for his valuable contribution during his tenure as Chair and I look forward to working with our excellent team...

Continue reading

Celldex Presents Unprecedented 76 Week Results from Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria at EAACI Congress 2025

Seven months after the completion of dosing:41% of patients (150 mg Q4W) continue to experience complete response (UAS7=0) 48% of patients (150 mg Q4W) report that CSU no longer impacts their quality of life (DLQI=0/1) KIT related tolerability events demonstrated to be reversibleEnrollment to Phase 3 CSU trials ongoing Company to host webcast today at 6:00 pm ETHAMPTON, N.J., June 12, 2025 (GLOBE NEWSWIRE) — Celldex (NASDAQ:CLDX) announced today new data demonstrating profound, sustained complete response and improved quality of life at 76 weeks, 7 months after the completion of dosing with barzolvolimab in chronic spontaneous urticaria (CSU), an immune-related condition driven by mast cell activation. Barzolvolimab specifically targets mast cells by binding the receptor tyrosine kinase KIT with high specificity and potently...

Continue reading

Pulse Announces a $13.5 Million Seismic Data License Sale and Provides Revenue Update

CALGARY, Alberta, June 12, 2025 (GLOBE NEWSWIRE) — Pulse Seismic Inc. (TSX:PSD) (OTCQX:PLSDF) (“Pulse” or the “Company”) is pleased to announce the sale of a significant seismic data license, valued at $13.5 million. On a preliminary basis, second quarter revenue to date approximates $17.2 million, including the license announced today. This brings year-to-date total licensing revenue to $40.0 million, reflecting an increase of 66% compared to the last three years average annual revenue. “I am pleased to announce this seismic data license sale,” stated Neal Coleman, Pulse’s President and CEO. “The sale delivers a strong contribution to the Company’s financial performance, particularly in terms of EBITDA and shareholder free cash flow. Our favourable financial outlook is underpinned by the Company’s low-cost operating structure...

Continue reading

Reykjavík Energy | Green Bond Auction June 19th

Reykjavík Energy (Orkuveita Reykjavíkur) is holding a bond auction on Thursday, June 19th, 2025. Bonds in the green bond classes OR031033 GB, OR280845 GB and OR180255 GB will be offered for sale. OR031033 GB bears 8.30% fixed nominal interest and pays equal instalments every six months with a final maturity date of October 3rd, 2033. Previously, bonds with a nominal value of ISK 8,990 million have been issued in the class and admitted to trading on Nasdaq Iceland. OR0280845 GB bears fixed indexed interest and pays equal payments every six months with a final maturity date of August 28th, 2045. The bond carries 3.70% fixed interest and is redeemable in the year 2037. Previously, bonds with a nominal value of ISK 8,000 million have been issued in the class and admitted to trading on Nasdaq Iceland. OR180255 GB bears fixed indexed interest...

Continue reading

Friedman Industries, Incorporated Announces Fourth Quarter and Fiscal Year 2025 Results

LONGVIEW, Texas, June 12, 2025 (GLOBE NEWSWIRE) — Friedman Industries, Incorporated (NASDAQ/GS: FRD) announced today its results of operations for the quarter and fiscal year ended March 31, 2025. March 31, 2025 Quarter Highlights:Net earnings of $5.3 million Sales of $129.2 million Highest sales volume in Company history 28% increase in sales volume over the preceding third quarter 5% increase in sales volume over the prior year fourth quarterFiscal Year March 31, 2025 Highlights:Net earnings of $6.1 million Sales of $444.6 million Working capital balance at year-end of $128.1 million“We ended fiscal 2025 with improved margins and a record quarter for sales volume as we continue to execute on our growth strategy,” said Michael J. Taylor, President and Chief Executive Officer. “Our fourth quarter sales volume increased...

Continue reading

FOBI AI Inc. Announces Closing of the Sale of German Subsidiary

Vancouver, BC, June 12, 2025 (GLOBE NEWSWIRE) — FOBI AI Inc. (FOBI:TSXV) (FOBIF:OTCQB) (“Fobi” or the “Company”) announces that further to its news release dated May 28, 2025, it has closed the sale (the “Transaction”) of all of its shares in Fobi AI Germany GmbH (the “Acquired Company”), its wholly owned German subsidiary, to an arm’s length third party purchaser (the “Purchaser”) pursuant to the terms of share purchase agreement dated May 28, 2025 (the “Agreement”). Pursuant to the Agreement, the Purchaser paid to FOBI an aggregate of EUR 1,540,000.00 consisting of a cash purchase price in the amount of EUR 1,400,000.00 (the “Purchase Price”) and an additional purchase price in the amount of EUR 140,000.00, which was paid by the Purchaser to the Acquired Company on behalf of FOBI after assumption by the Purchaser of FOBI’s obligations...

Continue reading

LGI Homes Launches New Premier Master Planned Community at Magnolia Woods

The Ranch Plan by LGI Homes at Magnolia WoodsThe Ranch Plan by LGI Homes at Magnolia Woods features three bedrooms, two bathrooms, and an additional flex room.The Maxwell Plan by Terrata Homes at Magnolia WoodsThe Maxwell Plan by Terrata Homes at Magnolia Woods features four bedrooms, three bathrooms, a spacious flex room, a separate game room space, and a covered rear patio. THE WOODLANDS, Texas, June 12, 2025 (GLOBE NEWSWIRE) — LGI Homes, Inc. (NASDAQ: LGIH) is excited to announce its brand-new, master planned community coming to the fast-growing Houston suburb of Magnolia, Texas. With a projected total of more than 1,300 single family homesites at full build out, Magnolia Woods will feature homes sold under both the LGI Homes and Terrata Homes brands. Homeowners at Magnolia Woods will enjoy a host of onsite...

Continue reading

Daré Bioscience Announces Adjournment of Annual Meeting of Stockholders

Meeting to Reconvene on Wednesday, July 9, 2025 SAN DIEGO, June 12, 2025 (GLOBE NEWSWIRE) — Daré Bioscience, Inc. (NASDAQ: DARE), a biopharmaceutical company driven by a mission to challenge the status quo, making women’s health a priority, today announced that the company’s 2025 annual meeting of stockholders (the “Annual Meeting”) was convened and adjourned without any business conducted due to lack of the required quorum. A quorum is necessary to hold the Annual Meeting. There were fewer than a majority of shares entitled to vote present, either in person or by proxy, at the Annual Meeting. The Annual Meeting therefore had no quorum and was adjourned to allow time to solicit additional proxies on behalf of the company’s board of directors. The Annual Meeting will reconvene at 9:00 a.m. Pacific Time on Wednesday, July 9,...

Continue reading

Hapbee Is Upgrading U.S. Listing to OTCID to Expand Investor Access and Increase Market Visibility

Hapbee Also Updates Status of Audited Financial Statements VANCOUVER, British Columbia, June 12, 2025 (GLOBE NEWSWIRE) — Hapbee Technologies Inc. (TSXV: HAPB | OTC: HAPBF) (“Hapbee” or the “Company”), a leading wearable wellness technology company, is pleased to announce that its U.S. listing has been upgraded from the OTC Pink Sheets to the newly established OTCID (OTC International Designated) tier on the OTC Markets Group platform. The Company will continue to trade under the symbol HAPBF once the upgrade is complete – effective July 1, 2025. This uplisting reflects Hapbee’s ongoing commitment to enhancing transparency, accessibility, and engagement with a broader and diversified group of U.S.-based retail and institutional investors aligned with Hapbee’s market rollout plans and broader growth strategy. “We are excited...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.